$BMY and Vedanta Biosciences Announce a New Clinical Collab to Evaluate OPDIVO and VE800 in Patients with Advanced or Metastatic Cancers VedantaBio httpsnews.bms.compressreleaserdnewsbristolmyerssquibbandvedantabiosciencesannoun

$BMY and Vedanta Biosciences Announce a New Clinical Collab to Evaluate OPDIVO and VE800 in Patients with Advanced or Metastatic Cancers ⁦ ⁦@VedantaBio⁩ https://news.bms.com/press-release/rd-news/bristol-myers-squibb-and-vedanta-biosciences-announ

02:17 EST 10 Dec 2018 | Odi Bruckman

$BMY and Vedanta Biosciences Announce a New Clinical Collab to Evaluate OPDIVO and VE800 in Patients with Advanced or Metastatic Cancers ⁦ ⁦ @VedantaBio⁩ https://news.bms.com/press-release/rd-news/bristol-myers-squibb-and-vedanta-biosciences-announce-new-clinical-collaborati …

More From BioPortfolio on "$BMY and Vedanta Biosciences Announce a New Clinical Collab to Evaluate OPDIVO and VE800 in Patients with Advanced or Metastatic Cancers ⁦ ⁦@VedantaBio⁩ https://news.bms.com/press-release/rd-news/bristol-myers-squibb-and-vedanta-biosciences-announ"